Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes -: The Finnish Diabetes Prevention Study

被引:68
|
作者
Laukkanen, O
Lindström, J
Eriksson, J
Valle, TT
Hämäläinen, H
Ilanne-Parikka, P
Keinänen-Kiukaanniemi, S
Tuomilehto, J
Uusitupa, M
Laakso, M [1 ]
机构
[1] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland
[2] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, Helsinki, Finland
[3] Social Insurance Inst, Dept Res, Turku, Finland
[4] Tampere Univ Hosp, Finnish Diabet Assoc, Tampere, Finland
[5] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
[6] Oulu Univ, Oulu Univ Hosp, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland
[7] Oulu Deaconess Inst, Dept Publ Hlth, Oulu, Finland
[8] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
[9] Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland
关键词
D O I
10.2337/diabetes.54.7.2256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired insulin secretion is a fundamental defect in type 2 diabetes. The aim of this study was to investigate whether single nucleotide polymorphisms (SNPs) in the genes regulating insulin secretion (SLC2A2 [encoding GLUT2], GCK, TCF1 [encoding HNF-1], HNF4A, GIP, and GLP1R) are associated with the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in participants of the Finnish Diabetes Prevention Study. With the exception of SLC2A2, other genes were not associated with the risk of type 2 diabetes. All four SNPs of SLC2A2 predicted the conversion to diabetes, and rs5393 (AA genotype) increased the risk of type 2 diabetes in the entire study population by threefold (odds ratio 3.04, 95% Cl 1.34 - 6.88, P = 0.008). The risk for type 2 diabetes in the AA genotype carriers was increased in the control group (5.56 [1.78-17.391, P = 0.003) but not in the intervention group. We conclude that the SNPs of SLC2A2 predict the conversion to diabetes in obese subjects with IGT.
引用
收藏
页码:2256 / 2260
页数:5
相关论文
共 50 条
  • [1] The genetic variation in the gene (TNMD) is associated with impaired glucose metabolism and conversion to type 2 diabetes in men of the Finnish Diabetes Prevention Study
    Tolppanen, A-M.
    Pulkkinen, L.
    Kolehmainen, M.
    Salopuro, T.
    Schwab, U.
    Tuomilehto, J.
    Uusitupa, M.
    [J]. DIABETOLOGIA, 2006, 49 : 36 - 36
  • [2] Evolutionary structural and functional conservation of an ortholog of the GLUT2 glucose transporter gene ( SLC2A2) in zebrafish
    Castillo, Juan
    Crespo, Diego
    Capilla, Encarnacion
    Diaz, Monica
    Chauvigne, Francois
    Cerda, Joan
    Planas, Josep V.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2009, 297 (05) : R1570 - R1581
  • [3] Progression from impaired glucose tolerance to type 2 diabetes in the Finnish Diabetes Prevention Study:: predictive power of immune markers
    Herder, C
    Peltonen, M
    Koenig, W
    Kräft, I
    Müller-Scholze, S
    Martin, S
    Lindström, J
    Kolb, H
    Tuomilehto, J
    [J]. DIABETOLOGIA, 2005, 48 : A95 - A95
  • [4] Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study
    Siitonen, Niina
    Pulkkinen, Leena
    Lindstrom, Jaana
    Kolehmainen, Marjukka
    Schwab, Ursula
    Eriksson, Johan G.
    Ilanne-Parikka, Pirjo
    Keinanen-Kiukaanniemi, Sirkka
    Tuomilehto, Jaakko
    Uusitupa, Matti
    [J]. CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [5] Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study
    Niina Siitonen
    Leena Pulkkinen
    Jaana Lindström
    Marjukka Kolehmainen
    Ursula Schwab
    Johan G Eriksson
    Pirjo Ilanne-Parikka
    Sirkka Keinänen-Kiukaanniemi
    Jaakko Tuomilehto
    Matti Uusitupa
    [J]. Cardiovascular Diabetology, 10
  • [6] Sleek Duration, Lifestyle Intervention, and Incidence of Type 2 Diabetes in Impaired Glucose Tolerance The Finnish Diabetes Prevention Study
    Tuomilehto, Henri
    Keinanen-Kiukaanniemi, Sirkka
    Peltonen, Markku
    Ilanne-Parikka, Pirjo
    Partinen, Markku
    Uusitupa, Matti
    Lavigne, Gilles
    Tuomilehto, Jaakko
    Eriksson, Johan G.
    Lindstrom, Jaana
    Herder, Christian
    Aunola, Sirkka
    [J]. DIABETES CARE, 2009, 32 (11) : 1965 - 1971
  • [7] The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus:: The Finnish Diabetes Prevention Study
    Todorova, B
    Kubaszek, A
    Pihlajamäki, J
    Lindström, J
    Eriksson, J
    Valle, TT
    Hämäläinen, H
    Ilanne-Parikka, P
    Keinänen-Kiukaanniemi, S
    Tuomilehto, J
    Uusitupa, M
    Laakso, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05): : 2019 - 2023
  • [8] SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma
    Kim, Yun Hak
    Jeong, Dae Cheon
    Pak, Kyoungjune
    Han, Myoung-Eun
    Kim, Ji-Young
    Liangwen, Liu
    Kim, Hyun Jin
    Kim, Tae Woo
    Kim, Tae Hwa
    Hyun, Dong Woo
    Oh, Sae-Ock
    [J]. ONCOTARGET, 2017, 8 (40) : 68381 - 68392
  • [9] The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome
    René Santer
    Sebastian Groth
    Martina Kinner
    Anja Dombrowski
    Gerard T. Berry
    Johannes Brodehl
    James V. Leonard
    Shimon Moses
    Svante Norgren
    Flemming Skovby
    Reinhard Schneppenheim
    Beat Steinmann
    Jürgen Schaub
    [J]. Human Genetics, 2002, 110 : 21 - 29
  • [10] No mutation in the SLC2A2 (GLUT2) gene in a Turkish infant with Fanconi-Bickel syndrome
    Ozer, EA
    Aksu, N
    Uclar, E
    Erdogan, H
    Bakiler, AR
    Tsuda, M
    Kitasawa, E
    Coker, M
    Ozer, E
    [J]. PEDIATRIC NEPHROLOGY, 2003, 18 (04) : 397 - 398